Research |
![]() ![]() ![]() ![]() ![]() |
Serial Number | 79327214 |
Registration Number | 6810969 |
Mark Drawing Code | 4000: Illustration: Drawing with word(s)/letter(s)/number(s) in Block form |
2021-06-03 | Application Filed |
2021-12-02 | Location: INITIAL REVIEW/SERIALIZATION BRANCH(MAILROOM) |
2021-12-02 | Status: Live/Pending |
2021-12-03 | Transaction Date |
2022-08-09 | Trademark Registered |
Owner: | ![]() |
Address | Rue d'Entre-deux-Villes 10 CH-1814 La Tour-de-Peilz CH |
Legal Entity Type | Société Anonyme (sa) |
Legal Entity State | CH |
Click the blue "Refresh" button to load certificates, specimines, application, and other documents.
International Codes: | 3 |
U.S. Codes: | 001,004,006,050,051,052 |
International Codes: | 5 |
U.S. Codes: | 005,006,018,044,046,051,052 |
International Codes: | 10 |
U.S. Codes: | 026,039,044 |
Type Code | Type |
---|---|
GS0031 | Cosmetic preparations based on non-medicinal liquids and a gel, for filling wrinkles, folds, scars, lips, for face and body contour and skin rejuvenation; skin care preparations; cosmetic preparations for wrinkled skin treatment; anti-wrinkle skin care preparations |
GS0051 | Pharmaceutical preparations and substances, namely creams and gels for use in dermatology; injectable pharmaceutical products for filling lines, wrinkles, scars, lips, for tightening the face and body contouring and for rejuvenating the skin; injectable dermal fillers; pharmaceutical preparations and substances, namely creams and gels for use in skin care; muscle relaxants; medicinal preparations for filling lines, wrinkles, scars, lips, for tightening the face and body contouring and for rejuvenating the skin; medical preparations consisting of a dermatological preparation; pre-filled syringes sold filled with injectable dermal fillers for filling lines, wrinkles, scars, lips, for tightening the face and body contouring and for rejuvenating the skin; Skin-care kits comprising dermatological preparations, and pre-filled syringes sold filled with injectable dermal fillers for filling lines, wrinkles, scars, lips, for tightening the face and body contouring and for rejuvenating the skin, sold together as a unit; pharmaceutical preparations for use in non-surgical restorative and beauty care treatments and in aesthetic dermatology; synthetic injectable material, namely, injectable dermal fillers for use in the treatment of fine lines and wrinkles and for rejuvenating the skin |
Description | Date | Event Coding |
---|---|---|
SN ASSIGNED FOR SECT 66A APPL FROM IB | 2021-12-02 | 1 REPR M: |
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM | 2021-12-03 | 2 NWOS I:Incoming Correspondence |
APPLICATION FILING RECEIPT MAILED | 2021-12-07 | 3 MAFR O:Outgoing Correspondence |
ASSIGNED TO EXAMINER | 2022-02-08 | 4 DOCK D:Assigned to Examiner |
NON-FINAL ACTION WRITTEN | 2022-02-11 | 5 CNRT R:Renewal |
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | 2022-02-12 | 6 RFCR E:E-Mail |
CHANGE OF NAME/ADDRESS REC'D FROM IB | 2022-02-25 | 7 ADCH M: |
REFUSAL PROCESSED BY MPU | 2022-03-15 | 8 RFRR P: |
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | 2022-03-15 | 9 RFCS P: |
TEAS RESPONSE TO OFFICE ACTION RECEIVED | 2022-03-18 | 10 TROA I:Incoming Correspondence |
CORRESPONDENCE RECEIVED IN LAW OFFICE | 2022-03-18 | 11 CRFA I:Incoming Correspondence |
TEAS/EMAIL CORRESPONDENCE ENTERED | 2022-03-18 | 12 TEME I:Incoming Correspondence |
REFUSAL PROCESSED BY IB | 2022-04-04 | 13 RFNT P: |
FINAL REFUSAL WRITTEN | 2022-04-11 | 14 CNFR R:Renewal |
FINAL REFUSAL E-MAILED | 2022-04-11 | 15 GNFR O:Outgoing Correspondence |
NOTIFICATION OF FINAL REFUSAL EMAILED | 2022-04-11 | 16 GNFN O:Outgoing Correspondence |
TEAS REQUEST FOR RECONSIDERATION RECEIVED | 2022-04-13 | 17 ERFR I:Incoming Correspondence |
CORRESPONDENCE RECEIVED IN LAW OFFICE | 2022-04-13 | 18 CRFA I:Incoming Correspondence |
TEAS/EMAIL CORRESPONDENCE ENTERED | 2022-04-13 | 19 TEME I:Incoming Correspondence |
EXAMINERS AMENDMENT -WRITTEN | 2022-04-15 | 20 CNEA R:Renewal |
EXAMINERS AMENDMENT E-MAILED | 2022-04-15 | 21 GNEA O:Outgoing Correspondence |
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | 2022-04-15 | 22 GNEN O:Outgoing Correspondence |
EXAMINER'S AMENDMENT ENTERED | 2022-04-15 | 23 XAEC I:Incoming Correspondence |
CHANGE OF NAME/ADDRESS REC'D FROM IB | 2022-04-16 | 24 ADCH M: |
APPROVED FOR PUB - PRINCIPAL REGISTER | 2022-04-18 | 25 CNSA O:Outgoing Correspondence |
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | 2022-05-04 | 26 NONP E:E-Mail |
PUBLISHED FOR OPPOSITION | 2022-05-24 | 27 PUBO A:Allowance for Publication |
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | 2022-05-24 | 28 NPUB E:E-Mail |
CORRECTION TRANSACTION RECEIVED FROM IB | 2022-06-11 | 29 CRCV M: |
REGISTERED-PRINCIPAL REGISTER | 2022-08-09 | 30 R.PR A:Allowance for Publication |
NOTICE OF REGISTRATION CONFIRMATION EMAILED | 2022-08-09 | 31 NRCC E:E-Mail |
CORRECTION FROM THE IB EXAMINED, NO ACTION IS NEEDED | 2022-08-09 | 32 CORN I:Incoming Correspondence |
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | 2022-11-09 | 33 FICR P: |
FINAL DISPOSITION PROCESSED | 2022-11-22 | 34 FIMP P: |
FINAL DISPOSITION NOTICE SENT TO IB | 2022-11-22 | 35 FICS P: |
FINAL DECISION TRANSACTION PROCESSED BY IB | 2022-12-12 | 36 FINO P: |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.